Abstract
The intestinal glucagon-like peptides, GLP-1 and GLP-2, are important regulators of nutrient intake, digestion, absorption and metabolism. Extensive studies have shown that the co-secretion of GLP-1 and GLP-2 is regulated by a variety of dietary nutrient, neural and endocrine inputs. Furthermore, secretion of these peptides is altered in a number of pathological conditions, including type 2 diabetes and obesity. The purpose of this review is to discuss the regulation of GLP-1 and GLP-2 secretion in both health and disease.
Key words
Glucagon-like peptide-1 - Glucagon-like peptide-2 - GLP-1 - GLP-2 - Secretion - L-cell - Intestine - Nutrient - Endocrine - Neural - Vagal
References
-
1
Drucker D J.
Biological actions and therapeutic potential of the glucagon-like peptides.
Gastroenterology.
2002;
122
531-544
-
2
Vilsboll T, Krarup T, Deacon C F, Madsbad S, Holst J J.
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
Diabetes.
2001;
50
609-613
-
3
Rask E, Olsson T, Soderberg S, Johnson O, Seckl J, Holst J J, Ahren B.
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.
Diabetes Care.
2001;
24
1640-1645
-
4
Ranganath L R, Beety J M, Morgan L M, Wright J W, Howland R, Marks V.
Attenuated GLP-1 secretion in obesity: cause or consequence?.
Gut.
1996;
38
916-919
-
5
Xiao Q, Boushey R P, Cino M, Drucker D J, Brubaker P L.
Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease.
Am J Physiol Regul Integr Comp Physiol.
2000;
278
R1057-1063
-
6
Jeppesen P B, Hartmann B, Hansen B S, Thulesen J, Holst J J, Mortensen P B.
Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.
Gut.
1999;
45
559-563
-
7
Eissele R, Goke R, Willemer S, Harthus H P, Vermeer H, Arnold R, Goke B.
Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
Eur J Clin Invest.
1992;
22
283-291
-
8
Kervran A, Blache P, Bataille D.
Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Endocrinology.
1987;
121
704-713
-
9
Orskov C, Holst J J.
Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).
Scand J Clin Lab Invest.
1987;
47
165-174
-
10
Drucker D J, Jin T, Asa S L, Young T A, Brubaker P L.
Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
Mol Endocrinol.
1994;
8
1646-1655
-
11
Reimer R A, Darimont C, Gremlich S, Nicolas-Metral V, Ruegg U T, Mace K.
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion.
Endocrinology.
2001;
142
4522-4528
-
12
Elliott R M, Morgan L M, Tredger J A, Deacon S, Wright J, Marks V.
Glucagon-like peptide-1 (7 - 36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.
J Endocrinol.
1993;
138
159-166
-
13
Xiao Q, Boushey R P, Drucker D J, Brubaker P L.
Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans.
Gastroenterology.
1999;
117
99-105
-
14
Burrin D G, Stoll B, Jiang R, Chang X, Hartmann B, Holst J J, Greeley G H Jr, Reeds P J.
Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough?.
Am J Clin Nutr.
2000;
71
1603-1610
-
15
Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Goke B.
Gastric emptying and release of incretin hormones after glucose ingestion in humans.
J Clin Invest.
1996;
97
92-103
-
16
Kreymann B, Williams G, Ghatei M A, Bloom S R.
Glucagon-like peptide-1 7 - 36: a physiological incretin in man.
Lancet.
1987;
2
1300-1304
-
17
Balks H J, Holst J J, von zur Muhlen A, Brabant G.
Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors.
J Clin Endocrinol Metab.
1997;
82
786-790
-
18
Unger R H, Ohneda A, Valverde I, Eisentraut A M, Exton J.
Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
J Clin Invest.
1968;
47
48-65
-
19
Kong M F, Chapman I, Goble E, Wishart J, Wittert G, Morris H, Horowitz M.
Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects.
Peptides.
1999;
20
545-551
-
20
Qualmann C, Nauck M A, Holst J J, Orskov C, Creutzfeldt W.
Glucagon-like peptide 1 (7 - 36)amide secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).
Scand J Gastroenterol.
1995;
30
892-896
-
21
Damholt A B, Buchan A M, Kofod H.
Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
Endocrinology.
1998;
139
2085-2091
-
22
Plaisancie P, Dumoulin V, Chayvialle J A, Cuber J C.
Luminal glucagon-like peptide-1 (7 - 36)amide-releasing factors in the isolated vascularly perfused rat colon.
J Endocrinol.
1995;
145
521-526
-
23
Brubaker P L.
Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides.
Endocrinology.
1991;
128
3175-3182
-
24
Roberge J N, Brubaker P L.
Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
Endocrinology.
1993;
133
233-240
-
25
Ferraris R P, Yasharpour S, Lloyd K C, Mirzayan R, Diamond J M.
Luminal glucose concentrations in the gut under normal conditions.
Am J Physiol.
1990;
259
G822-837
-
26
Hansen L, Hartmann B, Mineo H, Holst J J.
Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
Regul Pept.
2004;
118
11-18
-
27
Reimann F, Gribble F M.
Glucose-sensing in glucagon-like peptide-1-secreting cells.
Diabetes.
2002;
51
2757-2763
-
28
Gribble F M, Williams L, Simpson A K, Reimann F.
A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line.
Diabetes.
2003;
52
1147-1154
-
29
Sasaki H, Manaka H, Yamatani K, Tominaga M.
GLP-1 secretion coupled with Na/glucose transporter from the isolated perfused canine ileum.
Digestion.
1993;
54
365-367
-
30
Ritzel U, Fromme A, Ottleben M, Leonhardt U, Ramadori G.
Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum.
Acta Diabetol.
1997;
34
18-21
-
31
Damci T, Yalin S, Balci H, Osar Z, Korugan U, Ozyazar M, Ilkova H.
Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients.
Diabetes Care.
2004;
27
1077-1080
-
32
Ranganath L, Norris F, Morgan L, Wright J, Marks V.
Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7 - 36)amide secretion by circulating non-esterified fatty acids.
Clin Sci (Lond).
1999;
96
335-342
-
33
Rocca A S, Brubaker P L.
Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in foetal rat intestinal cultures.
Endocrinology.
1995;
136
5593-5599
-
34
Rocca A S, LaGreca J, Kalitsky J, Brubaker P L.
Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
Endocrinology.
2001;
142
1148-1155
-
35
Adrian T E, Ballantyne G H, Longo W E, Bilchik A J, Graham S, Basson M D, Tierney R P, Modlin I M.
Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon.
Gut.
1993;
34
1219-1224
-
36
Dumoulin V, Moro F, Barcelo A, Dakka T, Cuber J C.
Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.
Endocrinology.
1998;
139
3780-3786
-
37
Borgstrom B, Dahlqvist A, Lundh G, Sjovall J.
Studies of intestinal digestion and absorption in the human.
J Clin Invest.
1957;
36
1521-1536
-
38
Fu-Cheng X, Anini Y, Chariot J, Castex N, Galmiche J P, Roze C.
Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut.
Pflugers Arch.
1997;
433
571-579
-
39
Roberge J N, Brubaker P L.
Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients.
Endocrinology.
1991;
128
3169-3174
-
40
Roberge J N, Gronau K A, Brubaker P L.
Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut.
Endocrinology.
1996;
137
2383-2388
-
41
Miyashita T, Hashimoto T, Gomez G, Townsend C M Jr, Greeley G H Jr, Thompson J C.
Neurotensin secretion in response to intraduodenal and intraileal administration of fat in dogs.
Biol Signals.
1992;
1
275-281
-
42
Rocca A S, Brubaker P L.
Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
Endocrinology.
1999;
140
1687-1694
-
43
Anini Y, Hansotia T, Brubaker P L.
Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats.
Endocrinology.
2002;
143
2420-2426
-
44
Anini Y, Brubaker P L.
Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L-cells.
Endocrinology.
2003;
144
3244-3250
-
45
Berthoud H R, Carlson N R, Powley T L.
Topography of efferent vagal innervation of the rat gastrointestinal tract.
Am J Physiol.
1991;
260
R200-207
-
46
Berthoud H R, Kressel M, Raybould H E, Neuhuber W L.
Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing.
Anat Embryol (Berl).
1995;
191
203-212
-
47
Claustre J, Brechet S, Plaisancie P, Chayvialle J A, Cuber J C.
Stimulatory effect of beta-adrenergic agonists on ileal L-cell secretion and modulation by alpha-adrenergic activation.
J Endocrinol.
1999;
162
271-278
-
48
Dumoulin V, Dakka T, Plaisancie P, Chayvialle J A, Cuber J C.
Regulation of glucagon-like peptide-1-(7 - 36)amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Endocrinology.
1995;
136
5182-5188
-
49
Orskov C, Holst J J, Knuhtsen S, Baldissera F G, Poulsen S S, Nielsen O V.
Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.
Endocrinology.
1986;
119
1467-1475
-
50
Herrmann-Rinke C, Voge A, Hess M, Goke B.
Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides.
J Endocrinol.
1995;
147
25-31
-
51
Persson K, Gingerich R L, Nayak S, Wada K, Wada E, Ahren B.
Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice.
Am J Physiol Endocrinol Metab.
2000;
279
E956-962
-
52
Tseng C C, Kieffer T J, Jarboe L A, Usdin T B, Wolfe M M.
Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
J Clin Invest.
1996;
98
2440-2445
-
53
Nauck M A, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7 - 36)amide infused at near-physiological insulinotropic hormone and glucose concentrations.
J Clin Endocrinol Metab.
1993;
76
912-917
-
54
Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J, Seino Y.
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.
Proc Natl Acad Sci U S A.
1999;
96
14 843-14 847
-
55
Anini Y, Brubaker P L.
Role of leptin in the regulation of glucagon-like peptide-1 secretion.
Diabetes.
2003;
52
252-259
-
56
Vilsboll T, Agerso H, Krarup T, Holst J J.
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.
J Clin Endocrinol Metab.
2003;
88
220-224
-
57
Brubaker P L, Drucker D J, Greenberg G R.
Synthesis and secretion of somatostatin-28 and -14 by foetal rat intestinaL-cells in culture.
Am J Physiol.
1990;
258
G974-981
-
58
Hansen L, Hartmann B, Bisgaard T, Mineo H, Jorgensen P N, Holst J J.
Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.
Am J Physiol Endocrinol Metab.
2000;
278
E1010-1018
-
59
Jia X, Brown J C, Kwok Y N, Pederson R A, McIntosh C H.
Gastric inhibitory polypeptide and glucagon-like peptide-1(7 - 36)amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.
Can J Physiol Pharmacol.
1994;
72
1215-1219
-
60
Brubaker P L, Efendic S, Greenberg G R.
Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release.
Endocrine.
1997;
6
91-95
Dr. P. L. Brubaker
Department of Physiology
Room 3366 · Medical Sciences Building · University of Toronto · 1 King’s College Circle · Toronto · ON M5S 1A8 Canada
Telefon: + 1(416)978-2593
Fax: + 1(416)978-2593 ·
eMail: p.brubaker@utoronto.ca
